Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Non-Current Assets (2016 - 2025)

Standard Biotools (LAB) has disclosed Non-Current Assets for 16 consecutive years, with $67.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Non-Current Assets fell 70.52% to $67.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $590.2 million, a 30.7% decrease, with the full-year FY2024 number at $236.5 million, up 43.44% from a year prior.
  • Non-Current Assets was $67.2 million for Q3 2025 at Standard Biotools, up from $50.9 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $236.5 million in Q4 2024 to a low of $50.9 million in Q2 2025.
  • A 5-year average of $180.3 million and a median of $198.7 million in 2022 define the central range for Non-Current Assets.
  • Peak YoY movement for Non-Current Assets: soared 176.9% in 2023, then crashed 77.73% in 2025.
  • Standard Biotools' Non-Current Assets stood at $203.1 million in 2021, then crashed by 70.69% to $59.5 million in 2022, then skyrocketed by 176.9% to $164.9 million in 2023, then soared by 43.44% to $236.5 million in 2024, then plummeted by 71.58% to $67.2 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Non-Current Assets are $67.2 million (Q3 2025), $50.9 million (Q2 2025), and $235.6 million (Q1 2025).